J.P. Morgan Healthcare Conference 2015

SOUTH SAN FRANCISCO, Calif. – Jan. 5, 2015 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Chief Executive Officer and President Gajus Worthington will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, on Thursday, January 15, 2015 at 8:30 a.m. (PT).

 

Audio of Fluidigm’s presentation will be webcast at:

 

http://jpmorgan.metameetings.com/confbook/healthcare15/directlink?p=17204.

 

The webcast will be archived for 90 days following the live presentation.

 

 

Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for growth markets such as single-cell biology and production genomics. We sell to leading academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multi-parameter mass cytometry technology, and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs, while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.

 

For more information, please visit www.fluidigm.com.

 

Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.

 

 

Ana Petrovic 

Director, Investor Relations & Strategy 

Fluidigm Corporation 

650 243 6628